Based on these numbers, the researchers estimated that 5-year cumulative risks of recurrent events were 17.4% for ischemic ...

The annual risk of recurrent ischemic stroke in patients with atrial fibrillation (AF) is about 3.75%, despite around 92% of ...

Although several recent articles have addressed practical considerations with respect to patient care with this class of drugs, 1 – 4 this review will explore mechanisms associated with the vascular ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to ...

Subgroup analyses demonstrated a low risk of adverse outcome in patients not meeting NICE imaging criteria except for taking an anticoagulant (2.7%, 95% CI 0.0% to 8.1%), or in asymptomatic, GCS 15 ...

Objectives To assess the risk of stroke/systemic embolism (SE) and major bleeding associated with the use of oral anticoagulants in elderly patients with atrial fibrillation (AF) in a real-world ...

This review explores mechanisms that influence age-related large elastic artery stiffening and endothelial dysfunction at the tissue level via inflammation and oxidative stress and at the cellular ...

This is possible only with an understanding, even an incomplete one, of ketamine’s mechanism of action, she says: “ ‘Why’ is not trivial.” John Krystal of Yale University, whose work ...

Background: Coagulation disorders are common complications in patients with pulmonary infections. Studies have suggested beneficial effects of anticoagulant therapies in patients with COVID-19.